<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 25-30% of childhood <z:hpo ids='HP_0004812'>pre-B cell acute lymphoblastic leukemias</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>) is characterized by the presence of a (1;19)(q23;p13.3) translocation </plain></SENT>
<SENT sid="1" pm="."><plain>The presence of this translocation is generally accompanied by a poor prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>The chimeric gene resulting from this chromosomal rearrangement encodes a hybrid transcription factor, E2A-Pbx1 </plain></SENT>
<SENT sid="3" pm="."><plain>In an attempt to delineate the genetic cascade initiated by E2A-Pbx1, we sought to identify genes that are deregulated by this transcription factor in t(1;19) <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We show here that the gene encoding the granulocyte colony-stimulating factor receptor (G-CSFr) is specifically upregulated in pre-B cells expressing E2A-Pbx1 </plain></SENT>
<SENT sid="5" pm="."><plain>G-CSFr is also expressed in cell lines established from t(1;19) pre-B cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> and on primary t(1;19) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, but not on control cells </plain></SENT>
<SENT sid="6" pm="."><plain>These data indicate that G-CSFr gene is a target for deregulation by E2A-Pbx1 </plain></SENT>
</text></document>